排序方式: 共有3条查询结果,搜索用时 563 毫秒
1
1.
2.
T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays 总被引:1,自引:1,他引:0
Stefan F. Martin Philipp R. Esser Sonja Schmucker Lisa Dietz Dean J. Naisbitt B. Kevin Park Marc Vocanson Jean-Francois Nicolas Monika Keller Werner J. Pichler Matthias Peiser Andreas Luch Reinhard Wanner Enrico Maggi Andrea Cavani Thomas Rustemeyer Anne Richter Hermann-Josef Thierse Federica Sallusto 《Cellular and molecular life sciences : CMLS》2010,67(24):4171-4184
Chemicals can elicit T-cell-mediated diseases such as allergic contact dermatitis and adverse drug reactions. Therefore, testing of chemicals, drugs and protein allergens for hazard identification and risk assessment is essential in regulatory toxicology. The seventh amendment of the EU Cosmetics Directive now prohibits the testing of cosmetic ingredients in mice, guinea pigs and other animal species to assess their sensitizing potential. In addition, the EU Chemicals Directive REACh requires the retesting of more than 30,000 chemicals for different toxicological endpoints, including sensitization, requiring vast numbers of animals. Therefore, alternative methods are urgently needed to eventually replace animal testing. Here, we summarize the outcome of an expert meeting in Rome on 7 November 2009 on the development of T-cell-based in vitro assays as tools in immunotoxicology to identify hazardous chemicals and drugs. In addition, we provide an overview of the development of the field over the last two decades. 相似文献
3.
Hamzah J Jugold M Kiessling F Rigby P Manzur M Marti HH Rabie T Kaden S Gröne HJ Hämmerling GJ Arnold B Ganss R 《Nature》2008,453(7193):410-414
The vasculature of solid tumours is morphologically aberrant and characterized by dilated and fragile vessels, intensive vessel sprouting and loss of hierarchical architecture. Constant vessel remodelling leads to spontaneous haemorrhages and increased interstitial fluid pressure in the tumour environment. Tumour-related angiogenesis supports tumour growth and is also a major obstacle for successful immune therapy as it prevents migration of immune effector cells into established tumour parenchyma. The molecular mechanisms for these angiogenic alterations are largely unknown. Here we identify regulator of G-protein signalling 5 (Rgs5) as a master gene responsible for the abnormal tumour vascular morphology in mice. Loss of Rgs5 results in pericyte maturation, vascular normalization and consequent marked reductions in tumour hypoxia and vessel leakiness. These vascular and intratumoral changes enhance influx of immune effector cells into tumour parenchyma and markedly prolong survival of tumour-bearing mice. This is the first demonstration, to our knowledge, of reduced tumour angiogenesis and improved immune therapeutic outcome on loss of a vascular gene function and establishes a previously unrecognized role of G-protein signalling in tumour angiogenesis. 相似文献
1